Dr. Rebecca B. Skolnick, Ph.D.

Dr. Rebecca B. Skolnick is Co-founder of MindWell NYC and a licensed clinical psychologist. She has particular expertise and interest in exposure therapy for phobias, anxiety, and obsessive compulsive disorder (OCD). Dr. Skolnick also specializes in cognitive behavioral therapy (CBT) and dialectical behavior therapy (DBT) for eating disorders in women and men. Dr. Skolnick provides individual and group therapy to adolescents, young adults, and adults.

Dr. Skolnick serves as an Adjunct Assistant Clinical Professor at Mount Sinai Hospital. She is the Membership Chair of the Association for Behavioral and Cognitive Therapies and a member of the New York City Cognitive Behavioral Therapy Association, Academy for Eating Disorders, and the New York Chapter of the International Association of Eating Disorders Professionals Foundation. She has several research publications and presentations related to anxiety disorders and eating disorders. Her dissertation research investigated the effects of a mindfulness-based instruction on anxiety and fear tolerance during an exposure procedure for claustrophobia.

Prior to founding MindWell NYC, Dr. Skolnick served as a staff psychologist and Director of the Eating Disorders Program at CBT/DBT Associates in New York City. Dr. Skolnick completed an externship and pre-doctoral clinical internship at Northwell Health, with rotations in the adolescent Eating Disorder Day Program, DBT adult outpatient clinic, adolescent inpatient unit, and geriatric partial hospital program. Dr. Skolnick also completed an externship and post-doctoral fellowship at CBT/DBT Associates working as an individual CBT and DBT therapist for adults, as well as a DBT skills group co-leader.

Dr. Skolnick earned her Ph.D. and M.A. in Clinical Psychology from Hofstra University, M.A. in Psychology in Education from Teachers College, Columbia University, and B.Sc. from Tufts University.

Are you worried you might be suffering from anxiety?

Take our free online Anxiety Questionnaire

This easy-to-use self-administered questionnaire is used as a screening tool and severity measure for generalized anxiety disorder (GAD).